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We investigated cells and conditioned media of the
three human keratinocyte cell lines HaCaT (non-tumo-
rigenic), A5 (benign, tumorigenic) and II-4RT (malig-
nant, tumorigenic) with regard to production and
secretion of the collagenases-1 to -3 (MMP-1, MMP-8
and MMP-13) and TIMP-1 using semi-nested RT-PCR,
Western blots, ELISA, immunocytochemistry and ca-
sein zymography.
Transcripts of MMP-1, -8, -13 and TIMP-1 were de-
tected in all cell lines by RT-PCR and the correspond-
ing proteins were found in the cytoplasm of all three
cell lines by Western blot analysis and/or immunocy-
tochemistry. The conditioned media of the malignant
II-4RT cells contain significantly more MMP-1 and
MMP-8 than those of HaCaT or A5 as evidenced by
immunoblotting and ELISA. In addition to the pres-
ence of latent MMP-1, zymography also detected the
active form of this enzyme. TIMP-1 was found only in
extracts of all three cell lines, predominantly in A5.
This study clearly indicates that the epithelial tumor
cells synthesize different collagenases and TIMP-1.
The malignant clone secretes increased amounts of
distinct collagenases compared to the non-tumori-
genic cell line, thereby verifying a correlation between
biological behaviour and the amount of collagenases.
In addition, we provide clear evidence that MMP-8 is
not exclusively found in polymorphonuclear granulo-
cytes, but also in keratinocyte cell lines.
Key words: Collagenase / HaCaT cells / In vitro study /
Keratinocyte cell lines / MMP / Tumorigenicity.
Introduction
The process of tumor invasion requires degradation of the
extracellular matrix by proteolytic enzymes (Matrisian
1992; Birkedal-Hansen et al., 1993). Therefore, the bal-
ance between production, activation and inhibition of
these enzymes is fundamental for the steps involved in the
tumor-associated matrix turnover (Schmitt et al., 1992;
Mignatti and Rifkin, 1993; Johnsen et al., 1998). In partic-
ular, an increased expression of matrix metalloproteinas-
es (MMPs) has been shown to be involved in tumor inva-
sion and metastasis (Basset et al., 1997; Johnsen et al.,
1998).
Until now more than 17 members of the family of zinc-
dependent MMPs have been identified (Woessner, 1998).
Due to their substrate specifity and structure, MMPs can
be classified into collagenases, stromelysins, gelatinases,
membrane-type MMPs and other MMPs (Kähäri and
Saarialho-Kere, 1997). During tumor invasion, collage-
nases are particulary important as these enzymes are able
to degrade the collagenous connective tissue which rep-
resents the bulk of the interstitial matrix.
The three mammalian collagenases known, i. e. the
fibroblast-type interstitial collagenase, the neutrophil col-
lagenase, and collagenase-3 differ in their substrate
preferences. The fibroblast-type interstitial collagenase
(MMP-1, collagenase-1; Goldberg et al., 1986) prefers
type III collagen over type I, II, VII and X (Gadher et al.,
1989; Seltzer et al., 1989). It is widely expressed in various
cell types including fibroblasts, chondrocytes, macro-
phages, endothelial cells and keratinocytes (Freije et al.,
1994). Increased levels of this enzyme have been detect-
ed in various carcinomas, e. g. thyroid and gastric cancer
(Kameyama, 1996, Sakurai et al., 1997a, b).
The neutrophil collagenase (MMP-8, collagenase-2;
Hasty et al., 1987) preferentially cleaves type I and II colla-
gens, but also type III collagen. This enzyme was thought
to be synthesized exclusively by polymorphonuclear neu-
trophils (PMN) where it is stored as a latent proenzyme in
the specific granules (Murphy et al., 1977; Mainardi et al.,
1991). However, in vivo MMP-8 expression has recently
been observed in mononuclear fibroblast-like cells in the
rheumatoid synovial membrane, and MMP-8 mRNA was
detected in cultured rheumatoid synovial fibroblasts, hu-
Bereitgestellt von | Universitaetsbibliothek der LMU Muenchen
Angemeldet | 129.187.254.47
Heruntergeladen am | 19.11.13 16:17
510 B.E. Bachmeier et al.
man endothelial cells and human chondrocytes (Chubin-
skaya et al., 1996; Cole et al., 1996; Hanemaaijer et al.,
1997).
The collagenase-3 (MMP-13; Freije et al., 1994) shows
an exceptionally wide substrate specifity compared to
other MMPs. In addition to fibrillar type I, II and III collagens
it also degrades type IV, IX, X and XIV collagen, gelatin,
tenascin, fibronectin and proteoglycan coreproteins
(Knäuper et al.,1996; Mitchell et al.,1996). Collagenase-3
is expressed by different malignant tumors including
breast carcinoma (Freije et al., 1994) and squamous cell
carcinoma of the skin, head and neck (Airola et al., 1997;
Johansson et al., 1997a; Cazorla et al., 1998).
Activation of MMPs is controlled by specific inhibitors,
termed ‘tissue inhibitors of metalloproteinases’ (TIMPs).
So far 4 TIMPs have been characterized which differ in
their inhibitory activities for the various MMPs. Thus,
TIMP-1 predominantly inhibits MMP-1, -3 and -9 (Mackay
et al., 1992), while TIMP-2 preferentially binds to MMP-2
(Goldberg et al., 1989). Besides these inhibitory effects,
TIMPs exert other biologically relevant functions and even
appear to be involved in the activation of certain MMPs.
So far it is unclear to what extent epithelial tumor cells
and the neighbouring stromal cells are responsible for the
elevated levels of collagenases in cancer tissues. In order
to elucidate the contribution of the tumor cells, we investi-
gated whether the differences in tumorigenicity in a model
system of three closely related human keratinocyte cell
lines (Boukamp et al., 1988, 1990) are reflected by their
profiles of constitutively expressed collagenases.
The cell lines investigated were HaCaT, a spontaneous-
ly immortalized human keratinocyte cell line (Boukamp et
al., 1988), and the two clones A5 and II-4RT which were
derived from HaCaT by stable transfection with the cellu-
lar Ha-ras oncogene (Boukamp et al., 1990). When im-
planted into athymic mice HaCaT cells are non-tumori-
genic, A5 cells form benign cysts and II-4RT cells develop
locally invasive squamous cell carcinomas. Thus the three
cell lines represent a unique model of closely related cells
with defined in vivo tumorigenicity.
Our approach is based on recent observations that 
in this model the amounts of gelatinases (MMP-2, -9) and
stromelysins (MMP-3, -7, -10) synthesized and secreted
increase with tumorigenicity, thus providing a potential
link between these enzymes and the cellular behaviour
(Bachmeier et al., 1998; 2000).
In the present study we provide evidence that all cell
lines express the collagenases MMP-1, -8 and -13 as well
as TIMP-1. Thus, MMP-8, the neutrophil collagenase, is
not specific for leukocytes, but can also be expressed by
epithelial tumor cells. The locally invasive cell line secretes
increased amounts of MMP-1 and -8; furthermore, in ad-
dition to the latent enzyme also active MMP-1 is present in
the media. These observations suggest that the collage-
nases expressed by epithelial tumor cells may directly
contribute to invasive tumor growth. In addition, the pres-
ence of several collagenases indicates the redundancy of
this proteolytic system.
Results
Detection of mRNAs of Collagenases and TIMP-1
Analysis of total RNA by semi-nested RT-PCR demon-
strated that the three cell lines express MMP-1 (Figure 1,
lanes 1 and 2), MMP-8 (lanes 3 and 4), MMP-13 (lanes 5
and 6) and TIMP-1 (lanes 7 and 8). Primers were chosen so
that the PCR amplicons included exon-exon transitions
(see Table 1) and thus amplification of genomic DNA
would result in products easily recognizable by their size.
In addition, the identity of the amplicons was verified by di-
gestion with restriction endonucleases (Table 1, Figure 1).
Detection of Collagenases and TIMP-1 in Cells 
and Cell Extracts
Protein expression of MMP-1, -8, -13 and TIMP-1 was de-
tected in extracts and conditioned media (see section be-
low) of all three cell lines by means of Western blots, im-
munohistochemistry, ELISA, and zymography; the high
Table 1 Primers Used for PCR Amplification.
Primer Sequence Location
MMP-1 forward 5´-AGATGTGGAGTGCCTGATGT-3´ exon 2
MMP-1 reverse (outer) 5´-CCTGCAGTTGAACCAGCTAT-3´ exon 9
MMP-1 reverse (inner) 5´-GTGCGCATGTAGAATCTGTC-3´ exon 7
MMP-8 forward 5´-ACCAATTACCAAGCAACCAG-3´ exon 2
MMP-8 reverse (outer) 5´-GGGATACATCAAGGCACCAG-3´ exon 5
MMP-8 reverse (inner) 5´-GAGCAGCAACAAGAAACAAG-3´ exon 5
MMP-13 forward 5´-CCAACCCTAAACATCCAAAAAC-3´ exon 6
MMP-13 reverse (outer) 5´-CACCACAAAATGGAATTTGCTG-3´ exon 9
MMP-13 reverse (inner) 5´-GGCATGACGCGAACAATAC-3´ exon 9
TIMP-1 forward 5´-CCAGAGAGACACCAGAGAAC-3´ exon 1/2
TIMP-1 reverse (outer) 5´-GAGGTAAGTGCCATGGTGAG-3´ exon 2
TIMP-1 reverse (inner) 5´-ACTCACCGAGGTCGGAATTG-3´ exon 2
All primers were designed using the GenBank cDNA sequences for MMP-1 (accession number
U78045), MMP-8 (accession number J05556), MMP-13 (accession number X75308), and TIMP-1
(accession number Y09720).
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sensitivity of zymography and immunohistochemistry al-
lowed to detect distinct proteins where the limits of the
Western blot technique were already reached. 
Western Blots MMP-1 was detected as faint bands 
of latent enzyme (52 kDa, Figure 2A) and MMP-13 as
bands of latent (52 kDa, Figure 2D) as well as active en-
zyme (42 kDa, Figure 2D). About equal amounts were
found in extracts of all three cell lines. MMP-8 was not de-
tected in the extracts of any cell line by immunoblotting.
In addition, bands of TIMP-1 at ~ 30 kDa were de-
tectable in extracts of all three cell lines. The intensity of
the TIMP-1 band was highest in benign A5 cell extracts
(Figure 2E; lane 3), lower in those of malignant II-4RT (Fig-
ure 2E; lane 4) and hardly detectable in those of HaCaT
(Figure 2E; lane 1) (see also Table 2).
Collagenases and TIMP-1 in Human Keratinocyte Cell Lines 511
Fig.1 Detection of MMP-1, -8, -13, and TIMP-1 mRNA by
Semi-Nested RT-PCR.
Data are shown for MMP-1 (lanes 1 and 2), MMP-8 (lanes 3 and 4),
MMP-13 (lanes 5 and 6) and TIMP-1 (lanes 7 and 8). Reverse tran-
scription and semi-nested PCR were performed with total RNA
from about 106 cells. Aliquots of the PCR mixtures before (lanes 1,
3, 5 and 7) and after digestion with restriction endonucleases
(lanes 2, 4, 6 and 8) were subjected to PAGE. The endonucleases
StyI, FokI, DdeI and HaeIII were used to digest amplicons from
MMP-1, -8, -13, and TIMP-1, respectively. The gels shown are the
results from HaCaT cells, representatively for all three cell lines.
Fig.2 Western Blot Analyses of Cell Extracts and Serum-Free
Conditioned Media of HaCaT, A5 and II-4RT Cells Using Antibod-
ies Specific for MMP-1, -8, -13, and TIMP-1.
Extracts (60 µg protein) analyzed for MMP-1 (A), MMP-13 (D), 
and TIMP-1 (E). Conditioned Media (15 µg protein) analyzed for
MMP-1 (B), and MMP-8 (C). HaCaT cells: lanes 3; A5 cells: lanes
4; II-4RT cells: lanes 5; MMP-1 and -8 controls (B, C): lanes 1:
without APMA; lanes 2: after APMA treatment.
Fig.3 Immunocytochemical Staining of MMP-1, MMP-8 and
MMP-13.
In all three cell lines a cytoplasmic positive staining was seen for
MMP-1 [HaCaT, (a); A5, (d); II-4RT, (g)] MMP-8 [HaCaT, (b); A5, (e);
II-4RT, (h)] and MMP-13 [HaCaT, (c); A5, (f); II-4RT, (i)]. Magnifica-
tion 340 x.
Table 2 Detection of MMP-1, -8, -13 and TIMP-1 in Extracts and Conditioned Media on Western
Blots. 
Extracts Conditioned media
HaCaT A5 II-4RT Form HaCaT A5 II-4RT Form
MMP-1 + + + latent + – +++ latent
MMP-8 – – – – ++ (+) +++ active
MMP-13 + + + latent – – – –
+ + + active
TIMP-1 + +++ ++ – – – – –
The intensities of the bands were scored from +++ (strong signal) to – (no signal).
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sent in media of HaCaT (Figure 2C, lane 3) and A5 cells
(hardly visible in Figure 2C, lane 4) and severalfold elevat-
ed in those of malignant II-4RT cells (Figure 2C, lane 5)
(see also Table 2). 
To verify whether the MMPs detected by Western blot-
ting represent the latent or the active forms, purified
MMP-1 and -8 with and without APMA treatment were
used as controls. The 52 kDa band of the cell culture su-
pernatants comigrated with the 52 kDa band of the control
(MMP-1 without APMA treatment; Figure 2B, lane 1), in-
dicating the presence of latent MMP-1 in the samples. In
addition also active MMP-1 (44-41 kDa) was visible in the
samples not treated with APMA (Figure 2B, lane 1). The 52
kDa band almost completely disappeared upon treatment
of MMP-1 with APMA, so that only the bands of active
MMP-1 (44-41 kDa) were visible (Figure 2B, lane 2). Appli-
cation of MMP-8 controls (latent form: Figure 2C, lane 1;
after APMA activation: Figure 2C, lane 2) demonstrated
that the 44 kDa band corresponded to the active form of
neutrophil collagenase (see also Table 2).
TIMP-1 and MMP-13 were not detectable in the condi-
tioned media of any of the cell lines.
ELISA The enhanced secretion of MMP-1 by the malig-
nant cells was confirmed and quantified by ELISA. As
shown in Figure 4, HaCaT cell culture supernatants con-
tained 19 pg/µg, those of benign A5 10.7 pg/µg and of
malignant II-4RT 36 pg/µg of secreted protein.
Zymography In addition to the latent form of MMP-1 (52
kDa) the active enzyme (41 kDa) was found in conditioned
media of benign A5 (Figure 5, lane 3) and malignant II-4RT
(Figure 5, lane 4) cells by means of zymography. Compar-
ison of the band pattern with that of MMP-1 controls clear-
ly demonstrated that the lytic zones at 52 and 41 kDa cor-
respond to the latent and active forms of MMP-1 (Figure 5,
lane 1). The amount of active interstitial collagenase is very
low and obviously below the detection limit of the less sen-
sitive Western blot technique. In addition to the bands cor-
responding to MMP-1 also lytic bands at 60 and 56 kDa
were obtained for all cell lines (Figure 5) which were not
further characterized in this study.
Immunocytochemistry The immunocytochemical  a-
nalysis revealed the presence of immunoreactive MMP-1,
-8 and -13 in all three cell lines, although to a different de-
gree. The enzymes were localized intracytoplasmatically
in a granular pattern. There was no accentuated mem-
brane staining. Using a scoring system (see also Table 3)
for the evaluation of the amounts of protein, we found
equally intense stainings for MMP-1 and -13 in HaCaT
(Figure 3a, g), A5 (Figure 3b, h) and II-4RT cells (Figure 
3c, i). In contrast, the MMP-8 staining score was lower in
HaCaT cells (Figure 3d) compared to the two tumorigenic
cell clones – the benign A5 cells (Figure 3e) and the malig-
nant II-4RT cells (Figure 3f) – which showed only minor dif-
ferences.
ELISA The amounts of MMP-1 protein in the cytoplasm
of the three cell lines were quantified by MMP-1-ELISA. 
As shown in Figure 4 the amounts of MMP-1 protein in 
HaCaT, A5 and II-4RT were virtually identical (1.3, 1.1, and
1.4 pg/µg of cellular protein, respectively).
Detection of Collagenases and TIMP-1 in
Conditioned Media
Western Blot In contrast to the analysis of cytoplasmic
collagenases-1 and -2 the pattern of secreted MMP-1 and
MMP-8 differed significantly between malignant II-4RT
cells and the other two cell lines (Figure 2B and 2C): while
MMP-1 could not be found in media of benign A5 cells
(Figure 2B, lane 4), it was present in small amounts in those
of normal HaCaT cells (Figure 2B, lane 3) and enhanced in
media of malignant II-4RT cells (lane 5). Secreted MMP-8
was visible as a 44 kDa band of active MMP-8. It was pre-
Table 3 Scoring of the Immunocytochemical Staining. 
HaCaT A5 II-4RT
MMP-1 12 12 12
MMP-8 3 6 7.5
MMP-13 8 8 8
Fig.4 Quantification of MMP-1 in Extracts and Conditioned
Media of HaCaT, A5, and II-4RT Cells. 
MMP-1 was quantified using the Amersham Biotrak MMP-1
ELISA kit. Values represent mean ± SD.
Fig.5 Casein-Zymography of Conditioned Media.
Lane 1, MMP-1 control; lanes 2 – 4, conditioned media of HaCaT,
A5 and II-4RT cells (20 µg protein per lane); lane 5, marker pro-
teins.
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Discussion
The dissolution of the extracellular matrix is a prerequisite
for invasive malignant growth. Recent studies provide a
large body of evidence that particularly matrix metallopro-
teinases (MMPs) are involved in this tissue degradation.
Based on their structures and substrate specificities the
MMPs have been classified into membrane-bound MMPs
(MT-MMPs), which are mainly involved in the activation of
non-bound MMPs, gelatinases (MMP-2, -9), which de-
grade non-helical collagen and non-collagenous proteins,
stromelysins (MMP-3, -7, -10, -11), which mainly dissolve
glycoproteins, and collagenases (MMP-1, -8, -13), which
are the only mammalian enzymes that are able to cleave
fibrillar collagens.
This substrate diversity is assumed to have major
biological implications, particularly during the invasive
growth of malignant tumors. Thus, the cleavage of the
basement membrane as the first barrier for malignant ep-
ithelial cells by gelatinases and stromelysins needs to be
followed by the breakdown of other interstitial collagen by
collagenases. The production and activation of collage-
nases therefore is pivotal for further tumor growth and lo-
cal tumor expansion. Indeed, various studies provide evi-
dence that in vivo an enhanced production of interstitial
collagenases is associated with a more aggressive growth
potential and poor clinical outcome (Murray et al., 1996,
1998; Cazorla et al., 1998; Airola et al., 1999; McCarthy et
al., 1999).
In a previous study (Bachmeier et al., 1998; 2000) we
have shown that HaCaT keratinocytes and the derived
clonal cell lines of different tumorigenicity represent an
interesting in vitro model for studying the biological role 
of the expression and secretion of gelatinases and
stromelysins: the malignant cell clone (termed II-4RT, de-
rived from the parental cell line HaCaT by c-Ha-ras onco-
gene transfection, Boukamp et al., 1990) produces larger
amounts of these enzymes than the benign cell line A5 and
particulary the parental non-tumorigenic cell line HaCaT.
This protease profile correlates well with the biological be-
haviour of these cell lines that has been extensively char-
acterized by implantation studies in athymic mice: injec-
tion of HaCaT cells resulted in rapidly regressing nodules,
A5 cells formed slowly expanding cysts without signs of
invasive growth, while II-4RT cells produced locally in-
vasive squamous cell carcinomas (Boukamp et al., 1990).
Thus, the enhanced production and secretion of gelati-
nases and to some extend of stromelysins in the tumori-
genic clones may result in the degradation of type IV colla-
gen and other components of the basement membrane.
In the present report we extended our studies on this
model system to the analysis of the collagenases MMP-1,
MMP-8 and MMP-13. These three collagenases are of
special interest because they are able to degrade fibrillar
collagens in the extracellular space, making them suscep-
tible to further degradation by other MMPs. Thus, secre-
tion of the collagenases enables tumor cells to invade the
interstitial matrix.
Using RT-PCR all three cell lines were shown to express
the mRNAs of MMP-1, -8, -13 and of TIMP-1, and thus are
capable to synthesize the corresponding proteins. On the
protein level, MMP-1 was significantly increased in the
media of malignant cells when compared to the benign A5
and the non-tumorigenic HaCaT. So far the expression 
of this enzyme in HaCaT keratinocytes has not been de-
scribed; however, several authors have reported the pres-
ence of MMP-1 in primary cultures of human squamous
cell carcinomas (Petersen et al., 1987; Bailly et al., 1990).
Interestingly, in addition to the latent form of MMP-1 also
the active enzyme was found in the media of tumorigenic
cell lines as detected by zymography, indicating that this
collagenase may be activated by the tumor cells them-
selves even without the support of stromal cells. The intra-
cellular levels of MMP-1 were about equal in the three cell
lines as shown by ELISA, immunocytochemistry and
Western blotting. The higher proportion of MMP-1 in me-
dia of the malignant II-4RT cells suggests that production
and secretion of MMP-1 in II-4RT cells are enhanced in
comparison to A5 and HaCaT cells and are linked to the
malignant infiltrative behaviour.
In addition to MMP-1, MMP-8 was detected in all cell
lines. The occurrence of this enzyme has so far not been
reported in epithelial tumor cell lines, but was found in the
granules of neutrophil leukocytes (Murphy et al., 1977;
Mainardi et al., 1991) and also in other non-epithelial cells
such as rheumatoid synovial fibroblasts, endothelial cells
(Hanemaaijer et al., 1997) and human chondrocytes (Chu-
binskaya et al., 1996; Cole et al., 1996). Cell-associated
MMP-8 was identified in all three cell lines by immunocy-
tochemistry, but not by Western blotting, most likely due
to the lower sensitivity of this technique. MMP-8 was
found on immunoblots of conditioned media of HaCaT
and II-4RT; larger amounts are secreted by the malignant
II-4RT than by non-tumorigenic HaCaT, while no MMP-8
was seen in media of A5 cells. As MMP-8 is known to hy-
drolyze native type I collagen with high efficiency (Hane-
maaijer et al., 1997), the secretion of this enzyme may be
important for the invasive behavior of tumor cells.
MMP-13 was observed exclusively in cellular extracts
as evidenced by Western blotting and by immunocyto-
chemistry, but not in conditioned media. This is well in line
with the previous report by Johansson et al. (1997b) who
did not find MMP-13 in the media of unstimulated HaCaT
cells; however, they reported that stimulation by TNF-
and TGF- resulted in a release of the enzyme into the me-
dia. In vivo studies on various tumors revealed MMP-13 to
be expressed by the epithelial tumor cells (Johansson et
al., 1997a; Cazorla et al., 1998; Balbin et al., 1999); in these
cases the expression of MMP-13 may be due to stimula-
tion by cytokines released e. g. by stromal cells.
The overall increased secretion of collagenolytic activi-
ty by II-4RT as compared to HaCaT and A5 cells seems to
be reflected in the in vivo behavior of the cells: while the
parental, non-tumorigenic HaCaT and the benign A5 cells
apparently do not destroy their surrounding interstitial ma-
trix in vivo, the malignant II-4RT cells show local dissolu-
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Harvesting of Cells Cells grown to confluence in serum-con-
taining medium were washed three times with 5 ml PBS and har-
vested by scraping in 5 ml PBS. The cell supensions were cen-
trifuged and the cells washed twice by suspension with 50 ml PBS
and centrifugation (10 min at 300 g). Aliquots of 1.5 – 1.7107
cells were stored at –70 °C until analysis.
Preparation of Cell Extracts 50 µl lysis buffer (10 mM Na3PO4;
0.4 M NaCl; 0.2 % Triton X-100) was added to an aliquot of frozen
cells. The mixture was sonified and after centrifugation for 14 min
at 15 000 g the supernatant containing the soluble proteins was
collected and either analyzed immediately or stored at –20 °C.
Determination of Protein Concentration Protein concentra-
tions were determined by the BCA protein assay (Pierce, Oud-
Beijerland, Netherlands) with bovine serum albumin as standard.
Zymography
Electrophoresis was carried out under non-reducing conditions.
After renaturation of the proteins by incubation of the gels in 25 g/l
Triton X-100 at room temperature for 2  10 min they were incu-
bated in 50 mM Tris-HCl, pH 7.5, containing 0.2 M NaCl, 0.02 %
Brij35 and 10 mM CaCl2 at 37 °C for 18 h. The gels were stained
with Coomassie Brilliant Blue R-250. After destaining zones of
proteolytic activity became visible as transparent bands in the
blue gel. 
As controls MMP-1 from human rheumatoid synovial fibrob-
lasts (Calbiochem, La Jolla, USA) and MMP-8 from human neu-
trophil granulocytes (Calbiochem) were used. Rabbit muscle
phosphorylase b, bovine serum albumin, ovalbumin, bovine car-
bonic anhydrase, soybean trypsin inhibitor, hen egg lysozyme
(Bio-Rad prestained markers, low range) were used as molecular
mass markers.
Reverse Transcription and Polymerase Chain Reaction
RNA Extraction Total RNA was extracted from cells according
to the method of Chomczynski and Sacchi (Chomczynski and
Sacchi, 1987) using TRI Reagent (Sigma, Deisenhofen, Ger-
many). Total RNA was quantified at 260/280 nm. Aliquots were
stored in DEPC-treated water or 0.1 M sodium acetate at –80 °C.
Reverse Transcription cDNAs were synthesized from 1 µg of
total RNA using the specific outer reverse primers (Table 1). Reac-
tions were carried out with the First Strand cDNA Synthesis Kit
(Pharmacia Biotech, Freiburg, Germany) following the manufac-
turer’s instructions.
Semi-Nested PCR The first round of PCR was carried out with
1/10 of the synthesized specific cDNA, 10 pmol of each primer, 40
nmol dNTP, 1 U PANScript polymerase (PAN-Systems), 2.5 µl
10x-buffer [16 mM (NH4)2SO4, 50 mM Tris/HCl, 0.1 g/l Tween-20,
pH 8.8] in a total volume of 25 µl. The MgCl2 concentration in the
reaction mixture was 6 mM for MMP-1, 2 mM for MMP-8 and -13,
and 3 mM for TIMP-1.
20 (MMP-1) or 25 (MMP-8, -13 and TIMP-1) cycles were carried
out with 30 s denaturation (94 °C), 30 s annealing (56 °C), and 30 s
(MMP-8, TIMP-1) or 1 min (MMP-1, MMP-13) synthesis (72 °C).
The second round of PCR with the forward and inner reverse
primers was carried out using one µl of the first PCR mixture in a
total volume of 50 µl and 35 PCR cycles. Concentrations of all
reagents and cycle profiles were as in the first PCR.
Negative controls were carried out in the same manner but
without template.
Characterization of RT-PCR Products PCR products were
characterized by restriction fragment analyses and size determi-
nation using polyacrylamide gel electrophoresis in 14 % gels con-
taining 10 % glycerol.
tion of the collagenous matrix (Boukamp et al., 1990) and
therefore require collagenolytic activity in order to grow
invasively.
Finally, we analyzed the expression of TIMP-1, which is
capable to inhibit most MMPs, particularly MMP-1 (Ma-
trisian, 1990). Interestingly, this inhibitor was detected in
extracts of all three cell lines but no secretion could be
demonstrated. The highest cell-associated levels were
found in the tumorigenic, benign A5 cells, intermediate in
malignant II-4RT cells, and the lowest in the non-tumori-
genic HaCaT cells. Thus the amounts of cellular TIMP do
not correlate well with those of the intracellular or secreted
MMPs. At present, the implication of these findings, par-
ticularly for the control of the collagenases, is unclear. This
subject is further complicated by the observation that
TIMPs are not only MMP-inhibitors, but are also involved
in protease activation (Strongin et al., 1995).
Taken together, the results presented support the con-
cept that the profile of MMPs synthesized and secreted by
tumor cells correlates with the invasive phenotype of the
respective cells. The increased constitutive secretion of
MMP-1 and -8 by the malignant II-4RT cells appears to 
be an important molecular tool for the degradation of the
extracellular matrix. Secretion and subsequent activation
of MMP-13 seems to require the interaction with stromal
cells, since this collagenase is found only in conditioned
media of TNF- / TGF- stimulated but not of unstimulat-
ed HaCaT keratinocytes (Johansson et al., 1997b). Sur-
prisingly, the cell lines not only synthesize the collagenas-
es MMP-1 and MMP-13, which are well known to be tu-
mor-associated, but also the neutrophil collagenase
MMP-8. Finally, the results confirm the conclusion of our
accompanying study (Bachmeier et. al., 2000) that the
system of the three keratinocyte cell lines can serve as a
highly valuable model for investigating correlations be-
tween the tumorigenic phenotype of cells and the expres-
sion of tumor-associated constituents.
Materials and Methods
Cells and Culture Conditions
Cell Culture Conditions The keratinocyte cell lines HaCaT, A5
and II-4RT (Boukamp et al., 1988, 1990) were cultured at 37 °C in
a humidified atmosphere of 5 % CO2 and 95 % air. The cells were
grown in DMEM (1 g/l glucose) supplemented with 10 % heat
inactivated fetal calf serum, 0.35 mg/ml L-glutamine and 0.05
mg/ml gentamycin sulfate; for A5 and II-4RT cells gentamycine
sulfate was substituted by 0.2 mg/ml geneticine. The medium
was changed every three days. For subcultures cells were har-
vested after brief treatment with 0.1 % trypsin/EDTA solution and
seeded at a dilution of 1:10. Cells between passages 12 and 55
were used for studies.
Preparation of Serum-Free Conditioned Medium Cells were
grown to approx. 90 % confluence in 75 cm2 plastic culture flasks
containing 15 ml medium. The cultures were rinsed three times
with Ca2+- and Mg2+-free PBS and subsequently 10 ml of serum-
free medium was added. After 2 days, the conditioned medium
was collected, concentrated by ultrafiltration (exclusion limit 10
kDa), and stored at –20 °C.
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Immunoblotting
Sixty µg protein of cell extract or 15 µg protein of conditioned me-
dia were subjected to SDS-PAGE in 10 % polyacrylamide slab
gels under non-reducing conditions. After electrotransfer to a ni-
trocellulose membrane and blocking with 50 g/l low fat dry milk
powder in TTBS (50 mM Tris-base, 150 mM NaCl, pH 7.5, 1 g/l
Tween-20) the membranes were incubated for 2 h in polyclonal
rabbit antiserum (for anti-MMP-1 see Lichtinghagen et al., 1995;
for anti-TIMP-1 see Geisler et al., 1997; anti-MMP-8 and -13 were
supplied by Dr. Harald Tschesche, Bielefeld), washed three times
for 10 min in TTBS, incubated for 1 h with a 1:1000 dilution of
porcine anti-rabbit immunoglobulin G alkaline phosphatase con-
jugate (DAKO) in 10 g/l low fat dry milk powder in TTBS. After rins-
ing twice with TTBS and once with TBS (TTBS without Tween), the
membrane was incubated with 5-bromo-4-chloro-3-indolyl
phosphate/nitro blue tetrazolium to visualize bands of alkaline
phosphatase activity.
Molecular mass marker proteins and purified MMP-1 (150 ng;
Calbiochem) and -8 (100 ng; Calbiochem) were used as controls;
in some experiments the purified MMPs were activated with
APMA prior to electrophoresis.
ELISA
MMP-1 was quantified in extracts and conditioned media from
different passages of the three cell lines using a MMP-1-ELISA Kit
(Biotrak, Amersham Buchler, Braunschweig, Germany). The anti-
body used in this ELISA recognizes the zymogen of MMP-1, the
active form and the complex with TIMP-1.
Immunocytochemistry
For the immunocytochemical localization of MMP-1, -8 and -13
cells were grown to confluence on silanized sterile glass slides
(SuperFrost plus). The medium was discarded, the cells rinsed
with Tris buffer, fixed in methanol/acetone (v/v 2:1) for two min-
utes, and rinsed again. Following incubation with the specific
polyclonal primary antibodies (see ‘immunoblotting’) for 30 min-
utes (37 °C), rinsing with Tris buffer, and application of the sec-
ondary antibody system (Streptavidin-Biotin-Complex method,
Hsu and Raine, 1981; DAKO, Hamburg, Germany), the resulting
antibody complexes were visualized with diaminobenzidine (Sig-
ma).
Using light microscopy the proportion of positively labeled
cells and the staining intensity was quantified. A five step grading
score was used for the proportion of stained cells (score 0: 0 cells
stained; score 1: 0 – 25 cells stained; score 2: 26 – 50 cells stained,
score 3: 51 – 75 cells stained; score 4: >75 cells stained) and a four
step grading for the staining intensity (score 0: no positive stain-
ing; score 1: faint positive staining; score 2: moderate staining;
score 3: strong staining intensity). 10 randomly selected areas
(each 0.41 mm2) on two different slides of each cell line were
evaluated.
This score was calculated by multiplication of the amount of
positively labeled cells and the staining intensity.
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